QWIXEL THERAPEUTICS, LLC
Los Angeles, CA · Biotech · Acquired
Masked interferon-alpha fusion proteins with tumor-activated proteolytic cleavage for targeted cancer immunotherapy
- Grants
- $600K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 3 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Novel Combination Therapy for the Treatment of Multiple Myeloma | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Protease Activated Masked Interferon to Treat Malignancy | $300,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3216 | Poplar Therapeutics | — | — |
| 3217 | MULTITARGA LLC | — | — |
| 3218 | Shield Pharma LLC | — | — |
| 3219 | QWIXEL THERAPEUTICS, LLC | — | — |
| 3220 | TARGAZYME, INC. | — | — |
| 3221 | Rondo Therapeutics | — | — |
| 3222 | GROW BIOMEDICINE LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Fusion Protein Composition(s) Comprising Masked Type I Interferons (ifna And Ifnb) For Use In The Treatment Of Cancer And Methods Thereofgranted
- Fusion Protein Composition(s) Comprising Masked Type I Interferons (ifna And Ifnb) For Use In The Treatment Of Cancer And Methods Thereofgranted
- Fusion Protein Composition(s) Comprising Masked Type I Interferons (ifna And Ifnb) For Use In The Treatment Of Cancer And Methods Thereofgranted
- Fusion Protein Composition(s) Comprising Masked Type I Interferons (ifna And Ifnb) For Use In The Treatment Of Cancer And Methods Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.